坦度螺酮对痛性糖尿病周围神经病的治疗作用(3)
[5] Galer BS,Jensen MP.Development and preliminary validation of a pain measure specific to neuropathic pain: the Neuropa thic Pain Scale[J]. Neurology,1997(48):332-338.
[6] Sang Soo Kim, Jong Chul Won, Hyuk Sang Kwon, et al. Vali dity of the medical outcomes study sleep scale in patients with painful diabetic peripheral neuropathy in Korea[J].J Diabetes Investig,2013,4(4):405-409.
[7] Mayumi Tsuji, Tetsuyuki Yasuda, Hideaki Kaneto, et al. Painful diabetic neuropathy in Japanese diabetic patients is common but underrecognized[J].Pain Res Treat,2013(2013): 318352.
[8] Tesfaye S,Boulton AJ, Dyck PJ, et al.Diabetic neuro pathies: up-date on definitions, diagnostic cri teria, estimation of severity, and treatments[J].Diabetes Care,2010(33):2285-2293.
[9] Feldman EL, Nave KA, Jensen TS, et al. New horizons in diabetic neuropathy: mechanisms, bioenergetics, and pain[J]. Neuron,2017,93(6):1296-1313.
[10] Tesfaye S, Boulton AJ, Dickenson AH. Mechanisms and management of diabetic painful distal symmetrical polyneuropathy[J]. Diabetes Care,2013,36(9):2456-2465.
[11] Huang X, Yang J, Yang S, et al. Role of tandospirone, a 5-HT1A receptor partial agonist, in the treatment of central nervous system disorders and the underlying mechanisms[J]. Oncotarget,2017,8(60):102705-102720.
(收稿日期:2018-09-07), http://www.100md.com(王蓉 李隆龄 吴雁 阳清伟 王凤 陈良义)
[6] Sang Soo Kim, Jong Chul Won, Hyuk Sang Kwon, et al. Vali dity of the medical outcomes study sleep scale in patients with painful diabetic peripheral neuropathy in Korea[J].J Diabetes Investig,2013,4(4):405-409.
[7] Mayumi Tsuji, Tetsuyuki Yasuda, Hideaki Kaneto, et al. Painful diabetic neuropathy in Japanese diabetic patients is common but underrecognized[J].Pain Res Treat,2013(2013): 318352.
[8] Tesfaye S,Boulton AJ, Dyck PJ, et al.Diabetic neuro pathies: up-date on definitions, diagnostic cri teria, estimation of severity, and treatments[J].Diabetes Care,2010(33):2285-2293.
[9] Feldman EL, Nave KA, Jensen TS, et al. New horizons in diabetic neuropathy: mechanisms, bioenergetics, and pain[J]. Neuron,2017,93(6):1296-1313.
[10] Tesfaye S, Boulton AJ, Dickenson AH. Mechanisms and management of diabetic painful distal symmetrical polyneuropathy[J]. Diabetes Care,2013,36(9):2456-2465.
[11] Huang X, Yang J, Yang S, et al. Role of tandospirone, a 5-HT1A receptor partial agonist, in the treatment of central nervous system disorders and the underlying mechanisms[J]. Oncotarget,2017,8(60):102705-102720.
(收稿日期:2018-09-07), http://www.100md.com(王蓉 李隆龄 吴雁 阳清伟 王凤 陈良义)